Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Current Assets (2018 - 2025)

Dna X filings provide 8 years of Current Assets readings, the most recent being $28.9 million for Q4 2025.

  • On a quarterly basis, Current Assets fell 10.12% to $28.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28.9 million, a 10.12% decrease, with the full-year FY2025 number at $28.9 million, down 10.12% from a year prior.
  • Current Assets hit $28.9 million in Q4 2025 for Dna X, down from $30.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $47.5 million in Q3 2023 to a low of $26.9 million in Q1 2025.
  • Median Current Assets over the past 5 years was $33.8 million (2022), compared with a mean of $35.3 million.
  • Biggest five-year swings in Current Assets: plummeted 43.04% in 2021 and later soared 39.42% in 2023.
  • Dna X's Current Assets stood at $35.7 million in 2021, then rose by 22.26% to $43.6 million in 2022, then rose by 0.36% to $43.8 million in 2023, then fell by 26.54% to $32.2 million in 2024, then fell by 10.12% to $28.9 million in 2025.
  • The last three reported values for Current Assets were $28.9 million (Q4 2025), $30.3 million (Q3 2025), and $27.1 million (Q2 2025) per Business Quant data.